The Role of Inflammatory Biomarkers in Disease Severity and Treatment Response across Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa—A Narrative Review - Summary - MDSpire
Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Exploring Inflammatory Biomarkers' Impact on Disease Severity and Treatment Efficacy in Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa: A Comprehensive Review
To evaluate the role of inflammatory biomarkers in assessing disease severity and treatment efficacy in chronic inflammatory skin diseases (CISDs) including psoriasis, atopic dermatitis, and hidradenitis suppurativa, with a focus on improving treatment strategies.
Key Findings:
The Fas/FasL axis contributes to chronic inflammation but evidence in HS is limited, indicating a need for targeted research.
IL-21 is linked to Th1 and Th17 activation and shows promise as a biomarker in PsO and AD, with a knowledge gap in HS that warrants further investigation.
CBC-derived inflammatory indices may correlate with disease activity and treatment response, but findings are inconsistent, necessitating standardization for clinical use.
Interpretation:
The findings highlight the complexity of immune-mediated pathways in CISDs and suggest that biomarkers could significantly enhance disease monitoring and treatment personalization, paving the way for future research.
Limitations:
Limited evidence for the role of certain biomarkers, particularly in HS, which may affect the generalizability of findings.
Heterogeneity in findings regarding CBC-derived indices necessitates standardization to ensure reliable clinical application.
Current studies are primarily retrospective, indicating a need for prospective validation to strengthen the evidence base.
Conclusion:
Integrating various biomarkers could lead to improved disease management strategies in CISDs, although further research is urgently needed to validate these findings and their clinical applicability.
Poorer dermatology-related quality of life was associated with greater mental health issues, while habitual probiotic intake showed no measurable relationship with these outcomes.
